In pharma/biotech, there are usually two career tracks: science leadership ladder and executive ladder. If you look at the profiles of bigger biotech companies on Yahoo Stocks, you will see that many C-level execs do not have a “Ph.D.” after their names: CEOs, COOs, VPs of Marketing, etc. However, there are not many examples of CSOs, VPs of R&D, etc. without an MD or a PhD. The main trick is to make the jump between the ladders, which probably means your D will need to get away from the bench and go into marketing, sales, compliance, QA, etc. Then an MBA will be quite helpful for her to begin her climb to the top. She does not have to quit her job to get an MBA; there are many excellent night MBA programs, like the one offered by my local flagship. There are tech management MBA programs as well that hold classes on weekends and certain weeknights. I am sure she can find excellent options in NYC! With her science background, subjects like microeconomics, statistics, linear programming, supply chain management, end even accounting will be a piece of cake. 
One more point: assuming she is currently at the bench, the sooner she makes the lateral move into a non-bench position, the better. Even entry-level positions require some relevant, e.g., marketing, experience, but if no suitable candidates are found, the preference will be given to a recent college grad without marketing experience over someone who has spent years at the bench. The assumption is that it is easier to train a recent college grad.